Skip to main content
. 2016 Oct 18;8(48):83469–83479. doi: 10.18632/oncotarget.12726

Table 2. The correlation between AKR7A3 methylation and expression level of AKR7A3 in HCC patients.

AKR7A3 down-regulation Total P value
Absent Present
AKR7A3 promoter Absent 33 (57%) 25 (43%) 58 (73%) 0.011
methylation Present 5 (24%) 16 (76%) 21 (27%)
Total 46 (48%) 33 (52%) 79